MarkellaVZanniMD
Endocrinology • Boston, MADiabetes, Lipid Metabolism
Instructor in Medicine, Massachusetts General Hospital
Are you Dr. Zanni?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 80 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
0 Emerson Pl
Suite 112
Boston, MA 02114Phone+1 617-726-6813Fax+1 617-726-1241- Is this information wrong?
Summary
- Dr. Markella Zanni, MD is an endocrinologist in Boston, Massachusetts. She is currently licensed to practice medicine in Massachusetts. She is affiliated with Massachusetts General Hospital and is an Instructor in Medicine at Massachusetts General Hospital.
Education & Training
Massachusetts General HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 2007 - 2010
Brigham and Women's HospitalResidency, Internal Medicine, 2004 - 2007
Harvard Medical SchoolClass of 2004
Certifications & Licensure
MA State Medical License 2007 - 2026- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Clinical Trials
- Monitoring and Modifying Atherosclerosis in Psoriasis Patients Study Start of enrollment: 2012 Feb 01
- Inflammation and Cardiovascular Health in Women Start of enrollment: 2020 Feb 03
Publications & Presentations
PubMed
- Cytomegalovirus IgG is Associated With Physical Function But Not Muscle Density in People With HIV.Maheen Z Abidi, Triin Umbleja, Edgar T Overton, Tricia Burdo, Jacqueline M Flynn, Michael T Lu, Jana Taron, Samuel R Schnittman, Kathleen V Fitch, Markella V Zanni, Ca...> ;Journal of Acquired Immune Deficiency Syndromes. 2024 Apr 15
- Polygenic Scores and Preclinical Cardiovascular Disease in Individuals With HIV: Insights From the REPRIEVE Trial.Yunfeng Ruan, Buu Truong, Michael T Lu, Júlia Karády, Rachel Bernardo, Phoebe Finneran, Whitney Hornsby, Kathleen V Fitch, Heather J Ribaudo, Pamela S Douglas, Steven ...> ;Journal of the American Heart Association. 2024 Apr 2
- Risk factors for clonal hematopoiesis of indeterminate potential in people with HIV: a report from the REPRIEVE trial.Bhattacharya, R., Uddin, M., Patel, A., Niroula, A., Finneran, P., Bernardo, R., Fitch, K., Lu, M., Bloomfield, G., Malvestutto, C., Aberg, J., Fichtenbaum, C., Hornsb...> ;Blood Advances. 2024 Feb 27
- Join now to see all
Press Mentions
Gulati: ASPC Summit to Explore ‘Protecting the Heart of One and All’July 22nd, 2021
REPRIEVE MR: Characterizing Cardiac Dysfunction in HIV and Testing the Effect of StatinsJuly 1st, 2017- Statins and HIV: How Can the REPRIEVE Findings Be Implemented in the Real World?July 28th, 2023
- Join now to see all
Grant Support
- Effects Of Tnf-A Antagonism In Patients With Obesity And Metabolic DysregulationNational Institute Of Diabetes And Digestive And Kidney Diseases2011
- Effects Of Tnf-Alpha Antagonism In Patients With Obesity And Metabolic DysregulatNational Institute Of Diabetes And Digestive And Kidney Diseases2010
Other Languages
- Greek
Hospital Affiliations
Massachusetts General HospitalBoston, Massachusetts
